Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Healthcare

India Gives 2 Lakh HCQ Tablets, Medical Supplies To Myanmar

The medical supplies sent by India also include surgical pumps, infusion pumps, syringe pumps, glucometer, thermal scanners and medical air compressors.

Read More

Health Professionals Contracting Coronavirus 'Matter Of Concern', Says Health Ministry

The remarks came after several cases of health professionals contracting coronavirus were reported across the country.

Read More

No Community Transmission Of COVID-19, Behavioural Changes May Help More: Harsh Vardhan

Underlining the importance of the lockdown, which has been extended till May 17, the minister said health should be on the radar just as much as the economy.

Read More

Moderna, Switzerland's Lonza Strike Deal On Potential COVID-19 Vaccine

Moderna got a $483 million funding from a U.S. government agency to accelerate its COVID-19 vaccine development.

Read More

Month Of May Could 'Make Or Break' Coronavirus Fight, Say Medical Experts

Medical experts feel an aggressive containment strategy in red zones and insulation of green zones is a must while giving relaxations.

Read More

India Has 'Gone Quite Ahead' To Win War Against COVID-19: Harsh Vardhan

While virtually interacting with civil society organisations (CSOs) and non-governmental organisations (NGOs) on COVID-19 issues at an event organised by Niti Aayog, Health Minister Harsh Vardhan said such organisations have been working tirelessly to ensure essential resources reach the last mile.

Read More

Glenmark To Conduct Trials In India For Potential COVID-19 Drug

Glenmark will initially enroll 150 patients with mild-to-moderate COVID-19 in a randomized trial that will compare favipiravir with standard supportive care.

Read More

Glenmark To Conduct Clinical Trials On Favipiravir Anti-Viral Tablets For COVID-19 Patients

Glenmark is the first pharmaceutical company in India to be given approval by the regulator to start the trial on COVID-19 patients in India.

Read More

Covid-19 Impact: Private Health Care Sector Fearing For Survival; Seeks Govt. Help

Drop in business makes the private healthcare players puts a big question-mark on their survival post-pandemic. Around 70 per cent of the healthcare services in India is provided by private healthcare players

Read More

GSK Profit Beats On Shingrix, Demand For Pain Meds During Pandemic

Turnover rose 19% to 9.09 billion pounds ($11.26 billion) in the three months ended March 31 from a year earlier, while adjusted earnings were 37.7 pence per share.

Read More

India's Serum Institute To Make Millions Of Potential Coronavirus Vaccine Doses

Serum, the world’s largest maker of vaccines by volume, is mass-producing the vaccine candidate developed by the University of Oxford, which started testing it on humans last week, and is a leader in the global race to develop an antidote to the novel coronavirus.

Read More

Novartis Wins Expanded European OK For Cosentyx Amid Pursuit Of $5 Billion Sales

European Commission (EC) approved Cosentyx for adult patients with active non-radiographic axial spondyloarthritis (nr-axSpA), characterized by chronic back pain.

Read More

Pfizer Sticks To Forecast After First-Quarter Profit Boost From Ibrance

Net income attributable to shareholders fell to $3.40 billion, or 61 cents per share, in the quarter, from $3.88 billion, or 68 cents per share, a year earlier.

Read More

#IndiaFightsCorona: Coronvirus Live Updates

This page has created to provide minute-by-minute updates on novel coronavirus outbreak with complete information and advice from various sector pioneers and government officials.

Read More

Diagnostic Business Under COVID Stress

Leading diagnostic chain Dr Lal PathLabs has seen an 80 per cent drop in business, Dr Arvind Lal tells BW Businessworld. Lal was recognized with Padma Shri in 2009, the fourth highest civilian honor, for his contributions to Medicine.

Read More